Skip to content

Mindfulness in pregnancy study

Identifying an optimal mindfulness intervention for pregnant women: a feasibility and acceptability study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11175222
Enrollment
30
Registered
2026-07-01
Start date
2021-08-08
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Singleton pregnancy Pregnancy and Childbirth

Interventions

Overview: Participants are randomized to one of two types of mindfulness courses, both lasting 8 weeks and delivered virtually over Zoom with a trained mindfulness instructor. For each course, weekly

Sponsors

UCI Health Susan Samueli Integrative Health Institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. >18 years age 2. Currently pregnant with one baby (no twins, triplets, etc.) 3. Between 14-27 weeks pregnant 4. Access to a computer, tablet or laptop with internet access

Exclusion criteria

Exclusion criteria: 1. Diagnosed with a major obstetric complication (congenital malformations/ fetal chromosomal abnormalities, placenta abruption, preeclampsia, or severe systemic/local infection) 2. Taking steroid medication 3. Receiving treatment (medication or other therapy) for a psychiatric condition 4. Non-fluent in English 5. Previously completed formal mindfulness training of any type 6. Unwilling/unable to attend the full course sessions over 8 weeks

Design outcomes

Primary

MeasureTime frame
Program feasibility measured using monitoring class attendance rates within each course at weekly timepoints throughout the 8 week course

Secondary

MeasureTime frame
Maternal perceived stress measured using the Perceived Stress Scale (PSS) at baseline and follow-up, after course completion;Maternal depressive symptoms measured using the Edinburgh Postnatal Depression Scale (EPDS) at baseline and follow-up, after course completion;Maternal anxiety measured using the State-Trait Anxiety Inventory (STAI) at baseline and follow-up, after course completion;Blood glucose measured using ELISA at baseline and follow-up, after course completion;Plasma C-reactive protein measured using ELISA at baseline and follow-up, after course completion;Plasma Interleukin-6 measured using electrochemiluminescence at baseline and follow-up, after course completion

Countries

United States of America

Contacts

Public ContactKaren Lindsay
kllindsa@uci.edu+1 9498240148

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026